GI Endoscopy · 3 min read
GLP-1 Agonists, NPO Status, and Aspiration Risk Before Endoscopy in 2026
A 24-hour clear-liquid day is the most consistent safety move. Holding a weekly dose helps EGD-only lists. Do not delay needed urgent endoscopy.
P26-09-20" data-astro-cid-gjtny2mx>Last reviewed September 20, 2026
Clinical Bottom Line
| Situation | 2026 practical answer |
|---|---|
| Asymptomatic patient, standard fast only | AGA rapid CPU: you may proceed. Residual gastric contents are still more common on GLP-1s. A 24-hour clear-liquid day is safer than a standard 8-hour solid fast. |
| Elective EGD on a weekly GLP-1 | ASGE 2025 suggests holding the weekly dose 7 days, or the daily dose 24 hours, plus 24-hour liquids. The 2026 OCULUS RCT found more clinically significant residual volume when the dose was continued, especially for EGD-only. |
| EGD plus colonoscopy after a full-day liquid prep | Residual contents drop sharply. Same-day colo is the best available mitigation if the drug was not held. |
| Nausea, vomiting, distention, or known gastroparesis | Do not treat this as a routine NPO. Consider delay, gastric ultrasound if you use it, or anesthesia with full-stomach precautions. |
| Urgent or emergent endoscopy | Do not delay needed endoscopy to complete a GLP-1 hold. Use aspiration precautions. |
The actual risk is a full stomach, not a pneumonia stampede
GLP-1 and dual GIP/GLP-1 agonists slow gastric emptying. Meta-analyses show more residual gastric contents and more aborted EGDs. They have not shown a clear increase in aspiration pneumonia. That distinction matters. You cancel or intubate for a stomach full of solids. You do not need a myth about epidemic Mendelson syndrome to take the residue seriously.
Standard ASA fasting still applies. It is not enough by itself on a GLP-1
| Intake | Usual ASA minimum | On a GLP-1 |
|---|---|---|
| Clear liquids | 2 hours | Keep. Encourage clears. Do not revert to NPO after midnight. |
| Light meal | 6 hours | Prefer a full clear-liquid day before elective endoscopy. |
| Heavy or fatty meal | 8 hours | Not an acceptable last meal the evening before an EGD on a GLP-1. |
Gastroparesis, achalasia, and gastric outlet obstruction still need a longer liquid run-in, GLP-1 or not.
Holds vs diet: the societies do not fully agree
Three documents are in active use, and they do not say the same thing:
- AGA rapid clinical practice update (2023/2024): If the patient followed a standard fast and has no nausea, vomiting, dyspepsia, or distention, proceed. A liquid day may be better than stopping the drug. Holding one weight-loss dose is optional, not mandatory.
- ASGE position statement (2025): Liquid diet for 24 hours in all GLP-1 users. For elective cases, hold daily agents 24 hours and weekly agents 7 days. Get anesthesia involved if the hold was missed or symptoms suggest delayed emptying.
- Multi-society / ASA 2024 shared guidance: Joint decision among endoscopist, anesthesia, and prescriber. Low-risk asymptomatic patients on stable doses may continue. Higher-risk patients follow a hold.
The 2026 OCULUS randomized trial (interim, then stopped early) found clinically significant residual gastric volume in 25% who continued the agonist versus 3% who held one dose. The gap was concentrated in EGD-only patients. Patients who also had colonoscopy after a clear-liquid day had no clinically significant residual volume. That is the most useful new number on this page.
A room rule you can actually run
- Ask every intake patient about weekly or daily GLP-1/GIP drugs by name (semaglutide, tirzepatide, liraglutide, dulaglutide, and the rest).
- Put elective EGD-only patients on 24-hour clears. Holding the weekly dose is reasonable and now has RCT support.
- If EGD is paired with colonoscopy, the liquid prep does most of the work. Still document the drug.
- On entry, look in the stomach before you commit to deep sedation without a plan. If you see a solid meal, stop. Protect the airway. Do not "just lavage and proceed" in an ambulatory room without anesthesia support.
- Do not postpone an urgent bleed, food impaction, or cholangitis case for a 7-day hold.
Antithrombotic holds are a different checklist. See antithrombotics around elective endoscopy.
Selected references
- Hashash JG, et al. AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy. Clin Gastroenterol Hepatol. 2024;22:705-707.
- ASGE. Position statement on periendoscopic management of patients on GLP-1 receptor agonists and SGLT-2 inhibitors. Gastrointest Endosc. 2025.
- GLP-1RA use and residual gastric contents and aspiration in GI endoscopy: systematic review and meta-analysis. Gastrointest Endosc. 2025;101:762-771.
- Holding vs continuing GLP-1/GIP agonists before upper endoscopy: the OCULUS randomized clinical trial. 2026.
Last reviewed September 20, 2026. Written for clinicians running elective and urgent endoscopy lists. Local anesthesia policy may be stricter than AGA guidance; agree the rule before the patient arrives.
For your teaching file
Save this article as a PDF
Drop your email and we'll open a print-ready version you can save as a PDF — and you'll start getting our weekly GI endoscopy newsletter.